Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;46(2):467-488.
doi: 10.3892/ijmm.2020.4608. Epub 2020 May 18.

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)

George Mihai Nitulescu  1 , Horia Paunescu  2 , Sterghios A Moschos  3 , Dimitrios Petrakis  4 , Georgiana Nitulescu  1 , George Nicolae Daniel Ion  1 , Demetrios A Spandidos  5 , Taxiarchis Konstantinos Nikolouzakis  4 , Nikolaos Drakoulis  6 , Aristidis Tsatsakis  4
Affiliations
Review

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)

George Mihai Nitulescu et al. Int J Mol Med. 2020 Aug.

Abstract

The major impact produced by the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) focused many researchers attention to find treatments that can suppress transmission or ameliorate the disease. Despite the very fast and large flow of scientific data on possible treatment solutions, none have yet demonstrated unequivocal clinical utility against coronavirus disease 2019 (COVID‑19). This work represents an exhaustive and critical review of all available data on potential treatments for COVID‑19, highlighting their mechanistic characteristics and the strategy development rationale. Drug repurposing, also known as drug repositioning, and target based methods are the most used strategies to advance therapeutic solutions into clinical practice. Current in silico, in vitro and in vivo evidence regarding proposed treatments are summarized providing strong support for future research efforts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phylogenetic tree of alpha-beta coronavirus.
Figure 2
Figure 2
Structure of RNA translation products of SARS-CoV-2 and untranslated regions. Adapted from (17).
Figure 3
Figure 3
Major therapeutical strategies in COVID-19.
Figure 4
Figure 4
Overview of mechanistic pathways and molecular targets of major potential COVID-19 treatments.
See this image and copyright information in PMC

References

    1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Fehr AR, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. doi: 10.1007/978-1-4939-2438-7_1. - DOI - PMC - PubMed
    1. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–423. doi: 10.1002/jmv.25681. - DOI - PMC - PubMed
    1. Tsatsakis A, Petrakis D, Nikolouzakis TK, Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis C, Aschner M, Hernández AF. COVID-19 an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence. Food Chem Toxicol. In Press. - PMC - PubMed
    1. Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii V, Spandidos DA, et al. COVID-19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review) Mol Med Rep. 2020;22:20–32. - PMC - PubMed

MeSH terms